Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732)
Status:
Terminated
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
This is a double-blind, double-dummy, prednisolone-controlled, multi-center, randomized,
parallel-group clinical study to evaluate the therapeutic efficacy of repeated infliximab
infusions in order to maintain Crohn's disease remission at the end of the study.